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Abstract. We studied using ultrasound investigation the changes of heart function parameters
as a result of acepromazine and xylazine administration in 9 adult horses, mixed breed. Comparing
with control group (unsedated horses) acepromazine induced RVFWs statistically increase (p<0,05).
Acepromazine also determined statistically decrease of LVIDd (p<0,05) resulting a decrease of Vd
(p<0.01). Xylazine induced decrease of LVFWd (p<0.01) and increase of Vd (p<0.5). Acepromazine
did not induce statistically significant changes on other parameters: RVFWd, RVIDs, RVIDd, IVSs,
IVSd, LVIDs, LVFWs and LVFWd. Comparing with control group, xylazine determined same results,
and did not influence RVFWs, LVIDd, Vs and Vd, so, acepromazine and xylazine did not induce any
statistically changes of  SF% and EF %.
Keywords: heart, echography, horse, tranquilizing drugs.
INTRODUCTION
Some sedatives used for general anesthesia in animals have not only beneficial effects
but also side effects which could be deadly for the pacient in some circumstances. We can
mentione about respiratory depression resulting hypoxemia and worsen of cardiac function
resulting decrease cardiac output. Peripheral vasodilatation induces by some sedatives
(acepromazine) cause decresed of cardiac output as a result of delay of venous reverse flow.
Decrease of the systolic ejection volume reduces blood flow in parenchymal organ and
consequently the function of that organ. Obvious, these hemodynamics changes are related
with drug type and dose (Hainisch, Hall, Oana). In horse’s surgery, acepromazine and
xylazine are very used because are cheap and easy to administrate and are only a few side
effects. However if we analyze the potential side effects of acepromazine and xylazine we
have to performe clinical exam of the patient before surgery focusing on the cardiovascular
system.
Ecography is non-invasive, modern technique used in horse cardiology for
identification of congenital and aquired heart diseases (Farrow). Nevertheless, for some
horses, we have to apply some restraint procedure or to traquilize the patient during
ultrasound investigation, procedures which can influence cardiac function. The magnitude of
these change depends on the accuratnes of matematical calculation of some parameters which
are related to the eficacy of the cardiac pomp (shortenig fraction and ejection fraction).
The aim of this paper was to evaluate ultrasound changes of cardiac parameters after
acepromazine and xylazine administration used for horse restraining.
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MATERIALS AND METHODS
The investigations were performed on Internal Medicine Department (Faculty of
Veterinary Medicine, Cluj-Napoca). The group contained nine horses mixed breed, clinical
healthy, with age between 8 and 14 years old, 5 female and 4 neutered male with 500 kg body
weight. Horses get used with physical and paraclinical examination from clinical activity with
the students. Before ultrasound investigation we performed clinical and ECG exams, as we
found out no valvular lesion or cardiac arrhythmia.
For echocardiographic investigation we used Mindray DP – 200 Vet device with has
broadband microconvex transducer (2.5 – 6 MHz). The ultrasonographic evaluation was
performed by right side aboard. We delimited area as follow: upwards from humerus line,
downwards from the elbow and in front of the back of the triceps muscle, the probe being
inserted in the space between ribs 4 and 5. Standard examination protocol consists in
transventricular short axis aboard at chordae tendineae level (between papillary muscle and
mitral valve). TM axe was placed perpendicularly on interventricular septum (Farrow).
All the images were taken from 21 – 24 cm deep and transductor frequency was set at
3.5 MHz. In these conditions we measured in M mode following parameters:
- RVFWs – right ventricular free wall in systole; RVFWd – right ventricular free wall in
diastole;
- RVIDs – right ventricular internal diameter in systole; RVIDd – right ventricular
internal diameter in diastole;
- IVSs – interventricular septum in systole; IVSd – interventricular septum in diastole;
- LVFWs – left ventricular free wall in systole; LVFWd – left ventricular free wall in
diastole;
- LVIDs – left ventricular internal diameter in systole; LVIDd – left ventricular internal
diameter in diastole ; B mode                           M mode e
All these parameters were evaluated in all horses before sedation. The average
examination time for each horse was 10 minutes. In this period we realized 3 consecutive
measurement, and final value was average of these values. Tranquilizers were injected i.v.
(acepromazine – 0.04 mg/bw, and xylazine 1.1 mg/bw) and the measurements were realized
10 minutes later. Between acepromazine and xylazine administration were  5 days for patient
recovery. This period was chosen for complete elimination of the tranquilizers from the body.
To evaluate systolic function were calculated for the left ventricle: shortening fraction
(SF%), diastolic and systolic volume (Vd, Vs) and systolic ejection fraction (EF%). The
formula for shortening fraction was: SF% = (LVIDd - LVIDs) / LVIDd x 100. Vd and Vs
were calculated using Teicholz's cubic formula V = (7 x LVID3) / (2.4 + LVID). For the
calculation of  left ventricular systolic ejection fraction we use the formula EF% = (VD - Vs) /
Vd x100. The dimensions of heart structures measure before tranquilizers administration were
mathematically evaluated obtaining average value and standard deviation. Some of the
obtained measurements were utilized to calculate left ventricular parameters function. Using
T student test we calculated the differences between anatomic dimensions of heart structure,
before and after sedation.
RESULTS AND DISCUTIONS
In this study we have investigated the effect of acepromazine and xylazine on
ventricular parameters. The effects of acepromazine and xylazine on cardiac function
parameters were evaluated in the dosage recommended by the manufacture. We chose horses
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from faculty property to minimize the effects of stress related with clinical and paraclinical
examination, so, the results obtained are the effect of sedative actions.
Our echocardiographic parameters obtained before sedatives administration are
presented in table nr.1. In the consulted literature we found out only values obtained from
sport horse, clinical healty, with different level of training. Some of these results are also
presented in table nr.1.
Tab. 1.
Reference values of the cardiac ultrasound parameters
obtained in M mode from unsedated horses
Parameter Current study Lescure and
Tamzali (1984)
Long (1992) dos Santos and
col., (2004)
RVFWd (cm) 1.59±0.36 - - -
RVFWs (cm) 2.97±0.42 - - -
RVIDd(cm) 3.6±0.91 3,86±0,62 3,83±0,91 2,04±0,55
RVIDs(cm) 2.50±1.32 - 2,71±1.00 1,61±0,71
IVSd(cm) 2.61±0.48 3,05±0,6 3,02±0,39 2,68±0,29
IVSs(cm) 3.88±0.70 4,81±7,03 4,55±0,55 4,17±0,42
LVIDd(cm) 9.43±1.88 11,05±1.34 11,9±0,71 9,72±0,72
LVIDs(cm) 4.42±1.31 6,10±0,90 7,35±0,72 5,94±0,96
LVFWd(cm) 2.66±1.06 2,91±0,49 - 2,69±0,32
LVFWs(cm) 4.14±1.70 4,44±0,58 3,96±0,63 4,23±0,69
SF % 52.53±13.49 44,13±6,43 38,76±4,59 39,06±7,66
EF % 77.78±11.29 - - 66,38±9,41
Vs (cm3) 117,99±79.14 - - 181,75±67,69
Vd (cm3) 519.87±189.79 - - 534,24±87,53
Average values of echocardiographic parameters 10 minutes after acepromazine and
xylazine administration are presented in table nr. 2. Our results from all horses, showed that
acepromazine (0.04 mg/bw) did not induce statistical changes in case of the next parameters:
RVFWd, LVFWs, LVFWd, RVIDs, RVIDd, IVSs, IVSd. The same results are available for
xylazine administration, in dose 1.1 mg/bw. Also, xylazine did not influence the values of
RVFWs, LVIDd, Vs and Vd compared with control group (unsedated horses). Acepromazine
induced statistical changes (p <0.05) in case of RVFWs compared with control group,
resulting a decrease of thickness of right ventricular systolic wall , but had no influence in
case of RVFWd (chart.1). This change shows a diminution of right ventricular contractual
capacity in conditions of unchanged diastolic relaxation. In case of left ventricular
myocardium, acepromazine decreases relaxation capacity to the end of diastole. In this
situation LVIDd decreased statistically significant (p < 0,05) (chart.2). This phenomenon is
suggested by a growth without statistic relevance of  LVFWd (3.44±1.33 cm) after
acepromazine administration, comparing with control group (2.66±1.06 cm). Acepromazine is
only sedative from this experiment with such effect in case of LVFWd because xylazine
influences conversely this parameter (chart. 3). This change is statistically ensure (p<0.01).
As a consequence of decrease LVIDd as a result of acepromazine administration, appears a
decrease of left ventricular diastolic volume (p < 0.01) comparative with control group. This
deficit of left ventricular relaxation to the end of diastole causes a significant decrease of
systolic volume (p <0.05). Comparing with xylazine, acepromazine has a strong effect in
reducing Vd. This result is statistically significant (P<0.05).
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Tab. 2
Acepromazine and xylazine effects on ultrasound cardiac parameters
Chart nr.1. Evolution of RVFWs and Chart nr.2. Evolution of LVIDs and
RVFWd  in unsedated and sedated horses LVIDd in unsedated and sedated horses
Chart nr.3. Evolution of LVFWs and Chart nr.4. The effect of acepromazine




RVFWs(cm) 2.97±0.42 2.54±0.56 (p<0,05) 2.82±0.52
RVFWd(cm) 1.59±0.36 1.64±0.41 1.54±0.37
RVIDs(cm) 2.50±1.32 2.02±1.00 1.95±1.27
RVIDd(cm) 3.60±0.19 3.31±0.94 2.79±1.19
IVSs(cm) 3.88±0.70 4.33±1.05 3.82±0.75
IVSd(cm) 2.61±0.48 2.93±0.55 2.62±0.50
LVIDs(cm) 5,11±0,74 3,75±1,58 4,56±0,66
LVIDd(cm) 10,37±0,37 7,56±1,41 (p<0,05) 8,94±0,38
LVFWs(cm) 4.14±1,70 4.67±1.02 3.81±1.11
LVFWd(cm) 2.66±1.06 3.44±1.33 (p<0,01) 2.20±0.40
SF% 50,82±5,72 52,61±16,66 48,89±7,30
EF% 77.78±11.29 81.61±12.37 78.89±8.63
Vs(cm3) 117.99±79.14 61.17±52.37 (p<0,05) 92.85±52.01
Vd(cm3) 519.87±189.79 298.60±123.73 (p<0,01) 434.18±182.95 (p<0,05)
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Comparing with control group, xylazine induced the decrees of Vs and Vd, but
these differences are not statistically significant (chart 4).
Shortening fraction is different influenced by these two sedatives (chart. 5).
Paradoxically, in dosage of 0.04 mg/bw determines an increase of  SF % comparing with
control group,   appearance which is the same in case of EF % (chart.5). Xylazine in
dosage of 1.1 mg/bw, determines reduction of SF % and increase of EF % (chart. 6).
Nevertheless standard deviation of the parameters (LVIDs, LVIDd, Vs and Vd)
use to calculate these values show that these increases are not statistically significant.The
most important standard deviation have been recorded in case of acepromazine
administration, without knowing of any credibile cause. These variability, after some
researcher, have been seen in horses of the same breend, even in the same horse in the
alternate day. So, variabillity coeficient from one day to other day are for IVSd and IVSs
<10 %, for LVIDd, LVIDs and SF% between 15-22%, and for LVFWd and LVFWs
between 26-43 % (8). We have to mentione, these coefficient of varibillity have been
determined on healty horses without administration of any sedatives. It is unprobable,
that sedatives administration could ameliorate these coefficient. Performing some
repetitive series of echocardiographies associated with get used of horses with this kind
of operation, decrease the variability and increase the precision of this investigation.
Chart nr. 5. The effect of acepromazine and
xylazine on SF%.
Chart nr.6. The effect of acepromazine and
xylazine on EF%.
Although our study have been performed in horses get used with ultrasound exam,
and because we investigated a small number of pacients, our results obtained before
sedatives administration are only informative. These served as reference values only for
this study, and these can not be used for other research. In this direction, could be
suggestive significant differnces of some parameters determined on horses in function of
height, age, level of training aspects underlining in other scientific papers.
The changes of SF % and EF % as a result of acepromazine administration, are
not statistically significant, and the bevaivour of these parameteres are in oposite
situation comparing with results of other researchers. Buhl and col. (2007) did not find
out any statistically significant changes following acepromazine administration in dosage
0.1 mg/bw. They also observed that detomidina (0.01 mg/bw) and romfidina (0.04
mg/bw) (α-2 agonist) induce statistically significant changes on LVIDd, LVIDs and FS
%. Xylazine (α-2 agonist) utilized in our study caused the same changes, with
particularity, these changes are not statistically significant.
Administration of acepromazine and xylazine for chemical restraint in horses
influence the accuracy of ultrasound investigation of the heart. These two sedatives
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influence sistolic and distolic dimensions of cardiac walls and also of ventricular cavities
resulting incorect data for SF % and EF %.
CONCLUSIONS
 Cardio effects of acepromazine administrations in horses consisted in statistically
significant decreases (P<0.05) of RVFWs, LVIDs and Vs are very statistically
significant of Vd (p<0.01) compared with control group.
 Comparing with acepromazine, xylazine reduced LVFWd (p<0.01) resulting
signicant increase of left ventricular’s Vd (p<0.05). Even if the change of these
parameters determined evident differences of SF % and EF %, the differences girlish
control groups were not statistically significant because of an individual reaction after
sedatives administration. To minimize the errors in heart ultrasound exploration in
horses we recommend to avoid acepromazine and xylazine administration for
chemical restraint.
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